Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06825533

The Prevalence of Prediabetes in Primary Care Medicine in Tunisia

The Prevalence of Prediabetes in Primary Care Medicine in Tunisia. a National Descriptive Cross-Sectional Study

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
5,000 (estimated)
Sponsor
Dacima Consulting · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study is national, observational and cross-sectional and aims to estimate the prevalence of prediabetes in primary care in Tunisia.

Detailed description

TN-PREDIAB is a Tunisian, descriptive, non-interventional, multicenter and cross-sectional clinical study performed in primary care facilities, of both public and private sectors. The study will screen ambulatory patients for at least 4 months to estimate the prevalence of prediabetes among enrolled subjects. The objectives of the study are: * Primary objective: to estimate the overall prevalence of prediabetes among Tunisian population * Secondary objective: * Describe the clinical and epidemiological profile of prediabetic subjects * Describe nutritional factors associated with prediabetes A Scientific Committee validates the scientific writing, a Steering Committee supervises the clinical operations of the project. Collected data are managed by the DACIMA Clinical Suite®, the electronic data capture platform which complies with the FDA 21 CFR part 11 requirements (Food and Drug Administration 21 Code of Federal Regulations part 11), the HIPAA specifications (Health Insurance Portability and Accountability Act), and the ICH standards (International Conference on Harmonisation).

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTFasting blood sugar levelAssess the level of Blood sugar level in fasting conditions at inclusion
DIAGNOSTIC_TESTGlycated hemoglobinAssess the level of glycated hemoglobin at inclusion

Timeline

Start date
2025-04-21
Primary completion
2025-08-21
Completion
2025-08-21
First posted
2025-02-13
Last updated
2025-02-25

Source: ClinicalTrials.gov record NCT06825533. Inclusion in this directory is not an endorsement.